Find here all our blog posts tagged with: regulatory science.

A regulator's desk piled with paper trial records next to a blueprint of an AI data center visible through the window, illustrating the gap between infrastructure investment and regulatory evidence capacity.

Capital Is Flowing to AI. Regulatory Science Capacity Is Not.

EU device rules, FDA benchmarking, and pharma's AI rollout share one constraint: regulators lack the evidence infrastructure to keep pace with deployment.